Priscilla Rupali

2.3k total citations
120 papers, 1.3k citations indexed

About

Priscilla Rupali is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Priscilla Rupali has authored 120 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Infectious Diseases, 43 papers in Epidemiology and 15 papers in Surgery. Recurrent topics in Priscilla Rupali's work include HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (14 papers) and Tuberculosis Research and Epidemiology (11 papers). Priscilla Rupali is often cited by papers focused on HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (14 papers) and Tuberculosis Research and Epidemiology (11 papers). Priscilla Rupali collaborates with scholars based in India, United Kingdom and United States. Priscilla Rupali's co-authors include Balaji Veeraraghavan, O C Abraham, Laura Nabarro, Naveen Kumar Devanga Ragupathi, Rajesh Kannangai, Abi Manesh, Joy S. Michael, Dilip Mathai, Chaitra Shankar and Mary S. Mathews and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Priscilla Rupali

107 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Priscilla Rupali India 22 644 437 190 175 163 120 1.3k
Monique Keuter Netherlands 23 558 0.9× 285 0.7× 96 0.5× 245 1.4× 190 1.2× 43 1.3k
Paul Cleary United Kingdom 18 929 1.4× 365 0.8× 221 1.2× 224 1.3× 58 0.4× 53 2.0k
Jack Lévy Belgium 23 586 0.9× 568 1.3× 171 0.9× 101 0.6× 225 1.4× 55 1.7k
Birkneh Tilahun Tadesse Ethiopia 16 333 0.5× 297 0.7× 199 1.0× 91 0.5× 92 0.6× 74 1.2k
Kinh Van Nguyen Vietnam 21 451 0.7× 439 1.0× 276 1.5× 46 0.3× 124 0.8× 52 1.4k
Naveet Wig India 24 1.2k 1.9× 522 1.2× 106 0.6× 139 0.8× 181 1.1× 206 2.2k
Christoph Hatz Switzerland 22 516 0.8× 295 0.7× 125 0.7× 102 0.6× 104 0.6× 53 1.3k
Folasade Ogunsola Nigeria 20 556 0.9× 377 0.9× 110 0.6× 147 0.8× 51 0.3× 80 1.3k
George Panos Greece 23 1.1k 1.7× 497 1.1× 101 0.5× 69 0.4× 424 2.6× 68 2.1k
Sasheela Ponnampalavanar Malaysia 22 674 1.0× 348 0.8× 211 1.1× 42 0.2× 104 0.6× 97 1.5k

Countries citing papers authored by Priscilla Rupali

Since Specialization
Citations

This map shows the geographic impact of Priscilla Rupali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priscilla Rupali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priscilla Rupali more than expected).

Fields of papers citing papers by Priscilla Rupali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Priscilla Rupali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priscilla Rupali. The network helps show where Priscilla Rupali may publish in the future.

Co-authorship network of co-authors of Priscilla Rupali

This figure shows the co-authorship network connecting the top 25 collaborators of Priscilla Rupali. A scholar is included among the top collaborators of Priscilla Rupali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Priscilla Rupali. Priscilla Rupali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gowri, Mahasampath, et al.. (2025). Prevalence and predictors of long COVID at 1 year in a cohort of hospitalized patients: A multicentric qualitative and quantitative study. PLoS ONE. 20(4). e0320643–e0320643. 1 indexed citations
3.
Rupali, Priscilla, et al.. (2025). Transplant Infectious Disease Training: Bridging the Gap. Transplant Infectious Disease. 27(4). e70060–e70060.
4.
Chaudhry, Dhruva, Ashutosh N. Aggarwal, Camilla Rodrigues, et al.. (2024). Cutaneous Tuberculosis. 2(1 Supp). S227–S228.
5.
6.
Rupali, Priscilla, Bhagteshwar Singh, Tom Solomon, et al.. (2024). The India brain infections guidelines project: Global evidence for local application. Clinical Epidemiology and Global Health. 27. 101560–101560.
7.
Rose, Winsley, Sudhir Babji, Anna George, et al.. (2023). Immunogenicity and safety of homologous and heterologous booster vaccination of ChAdOx1 nCoV-19 (COVISHIELD™) and BBV152 (COVAXIN®): a non-inferiority phase 4, participant and observer-blinded, randomised study. The Lancet Regional Health - Southeast Asia. 12. 100141–100141. 11 indexed citations
8.
Webster, Jemin, et al.. (2023). Establishing an effective antimicrobial stewardship program at four secondary-care hospitals in India using a hub-and-spoke model. SHILAP Revista de lepidopterología. 3(1). e99–e99. 7 indexed citations
9.
Gunasekaran, Karthik, et al.. (2023). Evaluation of Remdesivir to the outcomes of hospitalized patients with COVID-19 infection in a tertiary-care hospital in southern India. The Journal of Infection in Developing Countries. 17(3). 304–310. 3 indexed citations
10.
Thomas, Regi, et al.. (2023). Clinico-Radiological Evaluation for Longitudinal Assessment in Central Skull Base Osteomyelitis: Proposal of Novel Scoring System. Indian Journal of Otolaryngology and Head & Neck Surgery. 75(4). 3553–3564.
11.
Abhilash, Kundavaram Paul Prabhakar, Hema Paul, M. Murugesan, et al.. (2022). Effectiveness of a monitored home isolation program for COVID-19 infection during the second wave of the pandemic. Medical Journal Armed Forces India. 80(3). 327–334.
12.
Murugesan, M., Padmanaban Venkatesan, Winsley Rose, et al.. (2022). Epidemiological investigation of the COVID-19 outbreak in Vellore district in South India using Geographic Information Surveillance (GIS). International Journal of Infectious Diseases. 122. 669–675. 5 indexed citations
13.
Murugesan, M., Prasad Mathews, Hema Paul, et al.. (2022). Protective effect conferred by prior infection and vaccination on COVID-19 in a healthcare worker cohort in South India. PLoS ONE. 17(5). e0268797–e0268797. 16 indexed citations
14.
Murugesan, M., et al.. (2022). Transmission Dynamics of COVID-19 and Utility of Contact Tracing in Risk Assessment of Health-Care Worker Exposure during COVID-19 Pandemic. Indian Journal of Community Medicine. 47(1). 82–86. 2 indexed citations
15.
Prakash, John Antony Jude, Dolly Daniel, Grace Rebekah, et al.. (2021). Autoantibodies Among HIV-1 Infected Individuals and the Effect of Anti-Retroviral Therapy (ART) on It. Current HIV Research. 19(3). 277–285. 2 indexed citations
16.
Maki, Gina, Ingrid Smith, Sarah Paulin, et al.. (2020). Feasibility Study of the World Health Organization Health Care Facility-Based Antimicrobial Stewardship Toolkit for Low- and Middle-Income Countries. Antibiotics. 9(9). 556–556. 20 indexed citations
17.
Rupali, Priscilla, John Victor Peter, Subramani Kandasamy, et al.. (2019). Impact of an antimicrobial stewardship intervention in India: Evaluation of post-prescription review and feedback as a method of promoting optimal antimicrobial use in the intensive care units of a tertiary-care hospital. Infection Control and Hospital Epidemiology. 40(5). 512–519. 27 indexed citations
18.
19.
Paul, Thomas V., Hesarghatta Shyamasunder Asha, Nihal Thomas, et al.. (2010). Hypovitaminosis D and Bone Mineral Density in Human Immunodeficiency Virus-Infected Men from India, with or without Antiretroviral Therapy. Endocrine Practice. 16(4). 547–553. 22 indexed citations
20.
Sivadasan, Ajith, O C Abraham, Priscilla Rupali, et al.. (2009). High rates of regimen change due to drug toxicity among a cohort of South Indian adults with HIV infection initiated on generic, first-line antiretroviral treatment.. PubMed. 57. 384–8. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monique Keuter Breakdown of academic impact, for papers by Paul Cleary Breakdown of academic impact, for papers by Jack Lévy Breakdown of academic impact, for papers by Birkneh Tilahun Tadesse Breakdown of academic impact, for papers by Kinh Van Nguyen Breakdown of academic impact, for papers by Naveet Wig Breakdown of academic impact, for papers by Christoph Hatz Breakdown of academic impact, for papers by Folasade Ogunsola Breakdown of academic impact, for papers by George Panos Breakdown of academic impact, for papers by Sasheela Ponnampalavanar
Rankless by CCL
2026